www.alldocs.info « cancers »
by www.alldocs.info
the most recent document references on :: cancers
Google
 
 Web   cancers.alldocs.info 
 
    Languages: malattie oncologiche  cancers  cancer  cancer  Krebse          Found 427 documents         Page 3 of 15   Pages:  <<  <  1  2  3  4  5  6  7  8  9  10  >  >> 
 
 
 
   cancers cancers
     kidney cancer kidney cancer
  cancers.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [61] Are deaths from liver cancer, kidney cancer, and leukemia ...
      PDF [136,2 KB]  From [www.txstate.edu]  Last viewed: 07.09.2006
Tel 800.880.1300 Volume 98 5 Number 10 51 Are deaths from liver cancer , kidney cancer , and leukemia clustered in San Antonio? F. BENJAMIN ZHAN, PHD INTRODUCTION Concerns have arisen that cancer mor- tality rates in San Antonio may be ele- vated (1,2). For example, Bradshaw (2) reported high mortality rates of liver cancer , lung cancer , kidney can- cer, and leukemia per square mile in some areas of San Antonio. However, without consideration of the underly- ing at-risk population and its associ- ated demographic characteristics, mortality rates per square mile alone may give a misleading picture of cancer mortality rates in San Antonio. In addi- tion, to avoid preselection bias, cancer mortality in the entire state of Texas should be analyzed first to determine whether cancer mortality rates are in- deed excessively higher ...

  [62] Highlights from the Third International Kidney Cancer Symposium ...
      PDF [7149,5 KB]  From [kidneycancerassociation.org]  Last viewed: 07.09.2006
KidneyCancer J O U R N A L Volume 2, Number 4 Winter 2004 An Educational Service for Medical Oncologists and Urologists Highlights from the Third International Kidney Cancer Symposium Pathophysiology of Renal Cell Carcinoma:An Essential Primer on Etiology,Tumor Growth Factors, and Therapeutic Targets Ronald M.Bukowski, MD , William Bro When Is Lymphadenectomy Indicated in Localized RCC? Bradley C.Leibovich, MD Clinical Trial Updates: Analyses by Principal Investigators Interview: Robert J.Motzer, MD ,Offers a Retrospective on RCC Research Highlights from the Third International Kidney Cancer Symposium Pathophysiology of Renal Cell Carcinoma:An Essential Primer on Etiology,Tumor ...

  [63] Kidney Cancer
      PDF [18,0 KB]  From [www.masterdocs.com]  Last viewed: 07.09.2006
Kidney Cancer The National Cancer Institute ( http://www. cancer .gov/ ), lists kidney cancer as one of 13 common causes of cancer and provides the following information. To obtain a free copy of this document, go to www.masterdocs.com . Understanding Cancer Cancer begins in cells, the building blocks that make up tissues . Tissues make up the organs of the body. Normally, cells grow and divide to form new cells as the body needs them. When cells grow old, they die, and new cells take their place. Sometimes this orderly process goes wrong. New cells form when the body does not need them, and old cells do not die when they should. These extra cells can form a mass of tissue called a growth or tumor . Not all tumors are cancer . Tumors can be benign or malignant : Benign tumors are not cancer : • Benign tumors are rarely life-threatening. ...

  [64] Kidney Cancer (Renal Cancer)
      PDF [104,2 KB]  From [www.patient.co.uk]  Last viewed: 07.09.2006
Kidney Cancer (Renal Cancer ) What are the kidneys? The two kidneys lie to the sides of the upper abdomen (the loins), behind the intestines, and either side of the spine. Each kidney is about the size of a large orange, but bean-shaped. A large renal artery takes blood to each kidney . The artery divides into many tiny blood vessels (capillaries) throughout the kidney . Tiny structures in the kidneys called nephrons 'filter' the blood contained in the capillaries. Water and waste materials which filter through the walls of the capillaries into the nephrons form urine. Urine passes along thin channels (tubules) which are part of each nephron, into larger channels (ducts) which drain the urine into the renal pelvis (the inner part of the kidney ). Urine passes down a tube called a ureter which goes from each kidney to the bladder. Urine is stored ...

  [65] Allogeneic Gene-Modified Tumour Cells in Metastatic Kidney Cancer ...
      PDF [210,5 KB]  From [www.img.cas.cz]  Last viewed: 07.09.2006
Abstract. An allogeneic irradiated RCC cell line, engi- neered to produce IL-2 (ACHN-IL-2), admixed with autologous metastatic formalin-treated tumour cells, was used to vaccinate ten MRCC patients in progres- sion of disease in spite of IL-2 immunotherapy. The cells were administered subcutaneously and/or intra- tumourally. Sixty-four MRCC patients in progressive disease, not treated by vaccination but receiving simi- lar IL-2 immunotherapy, were considered as the con- trol group. Patients received 4ñ16 injections (mean 9 ± 4), contain- ing an average of 10.6 x 10 7 ± 7.7 x 10 7 ACHN-IL-2- transfected cells (a minimum of 4 x 10 7 , and a maximum of 31 x 10 7 ). Four patients also received intra-tumour injections. Vaccination was administered during 30ñ418 days, and the follow-up ...

  [66] EPIDEMIOLOGY AND RISK FACTORS OF KIDNEY CANCER Vladimír Janout ...
      PDF [261,6 KB]  From [publib.upol.cz]  Last viewed: 07.09.2006
95 EPIDEMIOLOGY AND RISK FACTORS OF KIDNEY CANCER Vladimír Janout, Gabriela Janoutová Department of Preventive Medicine, Faculty of Medicine, Palacký University, Hnevotínská 3, 77515 Olomouc, Czech Republic Received: May 15, 2004; Accepted: June 22, 2004 Key words: Kidney cancer /Epidemiology/Risk factors This review article presents kidney cancer epidemiology as well as main environmental and life style risk factors. INTRODUCTION Kidney cancer is the most important cancer site be- cause of high lethality rates and increasing incidence in some parts of the world mainly among all Caucasian popu- lations and in Japan. There were approximately 189 000 kidney cancers in the year 2000 worldwide, two-thirds of which occurred in developed countries 1 in connection with higher prevalence of different risk factors. The majority of cancers among adults, ...

  [67] KIDNEY CANCER AT A GLANCE
      PDF [100,2 KB]  From [www.antigenics.com]  Last viewed: 07.09.2006
KIDNEY CANCER AT A GLANCE What is kidney cancer ? Kidney cancer is an abnormal, uncontrolled growth of cells in the kidney . According to the American Cancer Society, the most common type is renal cell cancer (also called renal cell carcinoma), which accounts for 85 percent of all kidney tumors. Renal cell cancer may develop in one or both kidneys. In the early stages, kidney cancer usually causes no obvious signs or symptoms. As kidney cancer grows, it may invade organs near the kidney such as the liver, colon or pancreas. Kidney cancer cells may also break away from the original tumor and spread (or metastasize) to other parts of the body such as the lymph nodes, bones or lungs, with about one third of cases showing metastasis at the time of diagnosis. How many people get kidney cancer ? The American Cancer Society predicts that ...

  [68] CANCER of the KIDNEY and RENAL PELVIS
      PDF [501,8 KB]  From [www.dsf.health.state.pa.us]  Last viewed: 07.09.2006
There were 1,974 cases of invasive cancer of the kidney and renal pelvis diagnosed in 2001 among residents of Pennsylvania, the highest annual number since statewide reporting began in 1985. Males had an average annual (1997-2001) age-adjusted incidence rate approximately twice that of females (17.8 and 9.1 per 100,000, respectively). For the years 1992 through 2001, annual numbers of cases and age-adjusted incidence rates for white and black males and white females have been on the increase. Among black females, the increase in the annual incidence rates peaked in 1998, thereafter the rates have been on the decline. There are few understood causes of kidney cancer ; however, cigarette smoking is an important risk factor. Approximately a quarter of all cases are caused by this behavior. As with age-adjusted rates, age-specific incidence rates were much higher among males for almost all age groups. Over 59 percent of the cases for 2001 ...

  [69] Dietary acrylamide and cancer of the large bowel, kidney, and ...
      PDF [94,6 KB]  From [www.pauldickman.com]  Last viewed: 07.09.2006
Dietary acrylamide and cancer of the large bowel, kidney , and bladder: Absence of an association in a population-based study in Sweden LA Mucci* ,1,2 , PW Dickman 1,3 , G Steineck 3 , H-O Adami 1,2 and K Augustsson 1 1 Department of Medical Epidemiology, Karolinska Institutet, Box 281, SE 171 77 Stockholm, Sweden; 2 Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, 9th floor, Boston, MA 02115, USA; 3 Department of Oncology and Pathology, Clinical Cancer Epidemiology, Karolinska Institutet, SE 171 76 Stockholm, Sweden Recently, disturbingly high levels of acrylamide were unexpectedly detected in widely consumed food items, notably French fries, potato crisps, and bread. Much international public concern arose since acrylamide has been classified ...

  [70] KIDNEY CANCER UK
      PDF [95,8 KB]  From [www.kcuk.org]  Last viewed: 07.09.2006
KIDNEY CANCER UK Fourth Annual Conference and AGM Saturday 22 May 2004 Wythenshawe Hospital South Manchester University Hospitals Trust Education and Research Centre PROGRAMME 09.00 onwards Registration, refreshments and information stalls including CancerBACUP , Manchester Welfare Rights and Benefits Service, South Manchester Healthy Living Network , The Neil Cliffe Cancer Care Centre (Wythenshawe Hospital) , Macmillan Cancer Information and Support Centre (Manchester Royal Infirmary) , Beechwood Cancer Care Centre, Stockport (complementary therapies), Patient Advice and Liaison Service (PALS, Wythenshawe Hospital) – the stalls will remain open until the end of the conference 09.30 Annual General Meeting of Kidney Cancer UK Limited (Open to all paid-up members of KCUK; agenda will be sent to members in advance) ...

  [71] Kidney cancer - Cancer survival, incidence and mortality in NSW ...
      PDF [141,0 KB]  From [www.nswcc.org.au]  Last viewed: 07.09.2006
Kidney Cancer survival, incidence and mortality in NSW 1994–2000 52 The Cancer Council NSW Kidney cancer • The five-year relative survival from kidney cancer in NSW between 1994 and 2000 was 58.4% • There was no area variation in the adjusted relative risk of excess death due to kidney cancer after shrinking • There were 3,665 new cases of kidney cancer in NSW in 1994 to 1998 (2,165 males and 1,500 females) and 1,472 deaths (785 males and 687 females) • There were 15 more new cases of kidney cancer than expected in males in Central Coast; there was no area variation in the excess number of new cases in females • There was no area variation in the excess number of deaths from kidney cancer in either males or females Table 24a: Five-year relative survival, relative risk of excess death due to cancer and excess cancer deaths ...

  [72] CANCER of the KIDNEY and RENAL PELVIS
      PDF [508,4 KB]  From [www.dsf.health.state.pa.us]  Last viewed: 07.09.2006
There were 1,854 cases of invasive cancer of the kidney and renal pelvis diagnosed in 2000 among residents of Pennsylvania, the highest annual number since statewide reporting began in 1985. Males had an average annual (1996-2000) age-adjusted incidence rate twice that of females (17.3 and 8.8 per 100,000, respectively). Annual numbers of cases and age-adjusted incidence rates by sex and race for 1991 through 2000 have all been on the increase. There are few understood causes of kidney cancer ; however, cigarette smoking is an important risk factor. Approximately a quarter of all cases are caused by this behavior. As with age-adjusted rates, age-specific incidence rates were much higher among males for almost all age groups. Nearly 61 percent of the staged cases for 2000 were diagnosed during the localized stage of the disease. During the five-year period of 1996-2000, over 69 percent of the invasive cases of kidney and renal pelvis ...

  [73] Understanding Kidney Cancer
      PDF [908,9 KB]  From [www.kidneycancervaccine.com]  Last viewed: 07.09.2006
Understanding Kidney Cancer Page 2 Your doctor has given you this brochure to help answer any additional questions you may have about renal cell carcinoma. Being faced with a possible diagnosis of cancer can be frightening, but learning all you can about the disease may help you better understand what is happening with your body and how you can take an active role in your treatment. This brochure will explain what kidney cancer is, how it is evaluated and the current treatments that are available. It also addresses your surgery and how you may feel afterwards. Remember that your doctor, nurses and other health care professionals are all available to assist you. Don’t be afraid to go to them if you need your questions answered or if you need help dealing with your emotional, financial and lifestyle concerns. Learning all you can will help you ...

  [74] TISSUE BIOMARKERS IN CANCER OF THE URINARY BLADDER AND KIDNEY High ...
      PDF [422,4 KB]  From [ethesis.helsinki.fi]  Last viewed: 07.09.2006
TISSUE BIOMARKERS IN CANCER OF THE URINARY BLADDER AND KIDNEY High-throughput tissue microarrays in the study of urinary tract malignancies Harri Visapää Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA, and Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland. Academic Dissertation To be publicly discussed with permission of the Medical Faculty of the University of Helsinki, in auditorium 3 of the Biomedicum Helsinki, Haartmaninkatu 8, on June 7th, 2003, at 12 noon. Helsinki 2003 Page 2 Supervised by Professor Aarno Palotie David Geffen School of Medicine at UCLA, Los Angeles, California, USA, and Finnish Genome Center, University of Helsinki, Helsinki, Finland Reviewed by Docent Martti Ala-Opas ...

  [75] Lung and kidney cancer mortality associated with arsenic in ...
      PDF [358,6 KB]  From [ehscenter.berkeley.edu]  Last viewed: 07.09.2006
Kidney Cancer What are the Kidneys? The kidneys are two bean-shaped organs located behind the abdomen on each side of the spine. The main job of the kidneys is to filter the blood and rid the body of liquid waste through the bladder. They also control the production of red blood cells and regulate blood pressure. What is Kidney Cancer? In adults, the most common type of kidney cancer is renal cell carcinoma which begins in the cells that line the small tubes (tubules) within the kidneys. It accounts for more than 90 percent of cancerous kidney tumors. Children are more likely to develop a kind of kidney cancer called Wilms’ tumor. What are the risk factors? Cigarette smoking increases the risk of developing renal cell carcinoma by about 40 percent. The risk decreases after smoking stops. Other risks include ...

  [76] Kidney Cancer
      PDF [137,2 KB]  From [p53.cancer.med.umich.edu]  Last viewed: 07.09.2006
Last revised: 1/20/03 University of Michigan Comprehensive Cancer Center Patient Education Document #0042 Jan03 Ed. Online version: http://www. cancer .med.umich.edu/learn/percpathways.htm University of Michigan Comprehensive Cancer Center Patient Education Resource Center (PERC) INFORMATION GUIDE Kidney Cancer The purpose of this information guide is to help patients newly diagnosed with Kidney Cancer and their families to find sources of information and support. This list is not meant to be comprehensive, but rather to provide starting points for information seeking. The materials can be found at the Patient Education Resource Center (PERC) of the University of Michigan Comprehensive Cancer Center in room B1-361. Pamphlets Available at the Patient Education Resource Center on Level B-1 National Cancer Institute. ...

  [77] KIDNEY CANCER STAGE FORM
      PDF [46,7 KB]  From [www.stonybrookhospital.com]  Last viewed: 07.09.2006
STATE UNIVERSITY OF NEW YORK UNIVERSITY HOSPITAL AND MEDICAL CENTER STONY BROOK, NEW YORK 11794 KIDNEY CANCER STAGE FORM Type of specimen __ Histopathologic Type __ Tumor Size _ Laterality: c Bilateral c Left c Right SIDE 1 OF 2 TU2C014 (9/02) Patient Name _ Date of Birth __ MR# __ Enc# __ Sex Race __ Pt Type: § In § Out § E.D Clin Path [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] Clin Path [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] DEFINITIONS Primary Tumor (T) ...

  [78] Nephrectomy (Removal of the Kidney) Kidney cancer is a common ...
      PDF [3,2 KB]  From [urology.ucsf.edu]  Last viewed: 07.09.2006
Nephrectomy (Removal of the Kidney ) Kidney cancer is a common malignancy with over 30,000 patients afflicted in the United States per year. The incidence of kidney cancer is increasing which is partially due to the increased use of cross-sectional imaging such as CT and MRI. At the UCSF Comprehensive Cancer Center, we provide state-of -the-art care to the entire spectrum of patients with renal cancer , from those with suspicious x-rays without a diagnosis to the care of patients with advanced or recurrent kidney cancer . Surgical removal of the cancer is the most effective form of treatment for patients whose cancer is confined to the kidney . Traditionally this has been through a procedure called radical nephrectomy. Radical nephrectomy is an open surgical procedure performed through an abdominal or flank incision during which the kidney , the fat surrounding the kidney and the adrenal gland or ...

  [79] 17 Cancer of the kidney
      PDF [534,6 KB]  From [www.aihw.gov.au]  Last viewed: 07.09.2006
74 17 Cancer of the kidney Summary During 1992–1997, one-year relative survival after diagnosis of cancer of the kidney was 77.2% for males and 73.5% for females, and five-year relative survival was 59.9% for males and 57.5% for females (Table 17.1). Relative survival ten years after diagnosis was 47.7% for males and 46.2% for females in 1987–1991, the most recent period for which ten-year relative survival data are available (Figure 17.2; Tables 17.2 and 17.3). Between 1982–1986 and 1992–1997, kidney cancer relative survival increased significantly. Five-year relative survival increased from 50.8% to 59.9% for males and increased from 49.4% to 57.5%for females. There was no significant change one year after diagnosis for males whereas for females, relative survival after one year increased from 67.4% to 73.5% (Figure 17.2; Tables 17.2 and 17.3). As age at diagnosis increased, five-year ...

  [80] Kidney-toxic And Cancer-causing Chinese Herbal Supplements Are ...
      PDF [15,3 KB]  From [www.citizen.org]  Last viewed: 07.09.2006
14 x Worst Pills, Best Pills News Kidney -toxic And Cancer -causing Chinese Herbal Supplements Are Recalled E ast Earth Herb, Inc. of Eugene, Oregon issued a recall on November 21, 2000, of its Jade Pharmacy brand Meridian Circulation tablets and liquid extract and Jade Pharmacy brand Quell Fire tablets because they present a serious health hazard to consumers. The prod- ucts contain aristolochic acid, a potent cancer -causing and kidney - toxic agent found in certain plants and botanicals. About 600 species of the plant family Aristolochiacea contain this chemical. Meridian Circulation and Quell Fire were distributed throughout the U.S. through a variety of complementary-alternative-medi- cine proponents. A list of the recalled products and their lot numbers appears on this page. We reported in the July 2000 ...

  [81] CANCER of the KIDNEY and RENAL PELVIS
      PDF [447,2 KB]  From [www.health.state.pa.us]  Last viewed: 07.09.2006
There were 1,699 cases of cancer of the kidney and renal pelvis diagnosed in 1998 among residents of Pennsylvania, the highest annual number since statewide reporting began in 1985. Males had an average annual (1994-98) age-adjusted incidence rate about twice that of females (14.3 and 7.2 per 100,000, respectively). Annual numbers of cases and age-adjusted incidence rates by sex and race for 1989 through 1998 have all been on the increase. There are few understood causes of kidney cancer ; however, cigarette smoking is an important risk factor. Approximately a quarter of all cases are caused by this behavior. As with age-adjusted rates, age-specific incidence rates were much higher among males for almost all age groups. Over 60 percent of all the cases for 1998 were diagnosed during the local stage of the disease. During the five-year period of 1994-98, over 70 percent of the cases of kidney and renal pelvis cancers were diagnosed ...

  [82] 19. MALIGNANT CANCER OF THE KIDNEY, EXCEPT RENAL PELVIS (summary)
      PDF [13,2 KB]  From [www.allirelandnci.org]  Last viewed: 07.09.2006
All-Ireland cancer statistics 1994-96 88 Kidney , except renal pelvis 19. MALIGNANT CANCER OF THE KIDNEY , EXCEPT RENAL PELVIS (summary) ICD-O.2 C64 ICD-10 C64 ICD-9 189.0 Figures presented here relate to kidney only, but comparison with EU figures is based on kidney in combination with renal pelvis (ICD-10 C65), ureter (C66), and urethra, paraurethral gland and unspecified urinary organs (C68). Key facts • Average of 341 new cases per year, 1994-96: 135 in females, 206 in males. • Average of 181 deaths per year: 68 in females, 113 in males. • Age-standardised incidence and mortality rates about twice as high in males as in females • 10th most common site for cancer incidence in males, 16th in females. • 10th most common cause of cancer deaths in males, 13th in females. • All-Ireland incidence rates (for kidney ...

  [83] 158-12 (9-16-00) Blood-cell transplants slow kidney cancer
      PDF [89,4 KB]  From [www.sciencenews.org]  Last viewed: 07.09.2006
Physicians call renal-cell cancer a silent malignancy because it usually develops in people without producing pain or other symptoms. If the cancer , which seldom responds to drugs, is detected while still confined to a kidney , removing that organ can save a patient. In most cases, however, this stealthy cancer spreads before it’s found and on average, is fatal within a year of diagnosis. Researchers now report some success in fighting this kidney cancer by using blood from a healthy sibling donor and enabling immune cells in it to take control of the cancer patient’s immune system. In 8 of 19 patients given this therapy, donor immune cells attacked the can- cer, sending it into full or partial remission, the scientists report in the Sept. 14 N EW E NGLAND J OURNAL OF M EDICINE . The study “opens new therapeutic possibilities not only for metastatic ...

  [84] Current Status of Partial Nephrectomy in the Management of Kidney ...
      PDF [136,4 KB]  From [www.moffitt.usf.edu]  Last viewed: 07.09.2006
removal of a perirenal fibrolipoma. Partial nephrecto- my to treat renal malignancy was first described in 1890 by Czerny. 2 In 1950,Vermooten 3 reported that peripherally located, encapsulated renal tumors could be removed by partial excision of renal tissue. Partial nephrectomy has now become a standard procedure for appropriately selected patients with renal cell car- cinoma (RCC). Indications Nephron-sparing surgery is indicated for cases in which a radical nephrectomy would render the patient anephric with a subsequent immediate need for dialy- Current Status of Partial Nephrectomy in the Management of Kidney Cancer Arndt van Ophoven, MD, Ke-Hung Tsui, MD, Oleg Shvarts, Sherelle Laifer-Narin, MD, and Arie S.Belldegrun, MD Background: The technique of partial nephrectomy for managing renal cancers is well recognized, but ...

  [85] 147-24 (6-17-95) Death halts trial of kidney cancer drug
      PDF [39,6 KB]  From [www.sciencenews.org]  Last viewed: 07.09.2006
Last week, a biotechnology company halted a clinical trial designed to test the effectiveness of an immune system molecule known as interleukin-12 (IL-12) against advanced kidney can- cer. The suspension came after 12 out of 17 enrolled patients were hospitalized and one of the 12 died. The company, Genetics Institute, in Cambridge, Mass., has declined to describe the symp- toms that the patients suffered because “it is too soon to determine what happened,” says company spokesman Dennis Harp. Initial information, Harp notes, indicates that the hospitalized participants appear to suffer from more severe versions of side effects observed in four preliminary clinical trials. The com- pany has yet to make those side effects public. Preliminary, or phase I, clinical trials are meant to establish safe dosages of an experimen- tal drug. The phase II trials that follow address the drug’s activity against a disease or condi- ...

  [86] CANCER of the KIDNEY and RENAL PELVIS
      PDF [357,1 KB]  From [www.health.state.pa.us]  Last viewed: 07.09.2006
14 x Worst Pills, Best Pills News Kidney -toxic And Cancer -causing Chinese Herbal Supplements Are Recalled E ast Earth Herb, Inc. of Eugene, Oregon issued a recall on November 21, 2000, of its Jade Pharmacy brand Meridian Circulation tablets and liquid extract and Jade Pharmacy brand Quell Fire tablets because they present a serious health hazard to consumers. The prod- ucts contain aristolochic acid, a potent cancer -causing and kidney - toxic agent found in certain plants and botanicals. About 600 species of the plant family Aristolochiacea contain this chemical. Meridian Circulation and Quell Fire were distributed throughout the U.S. through a variety of complementary-alternative-medi- cine proponents. A list of the recalled products and their lot numbers appears on this page. We reported in the July 2000 ...

  [87] JAMA Patient Page Kidney Cancer
      PDF [249,2 KB]  From [jama.ama-assn.org]  Last viewed: 07.09.2006
Issue 65 Spring 2006 10 State Cancer Legislative Database Update, NCI Adopted Resolutions (n=4) Governor’s s Proclamations (n=2) Introduced/Pending Measures (n=5) Legislative Data Byte It is predicted that more than 38,000 new cases of kidney cancer will be diagnosed in the United States during 2006. 1 Kidney cancer develops most often in people over the age of 40 and occurs twice as often in males as in females,but no one knows the exact causes of this disease. 2 There are more than 100,000 kidney cancer survivors living in the United States. 3 Often, kidney cancers are found "incidentally," meaning that the cancer is found during medical tests for some other illness such as gallbladder disease. 1 However,because the symptoms of kidney cancer can often be mistaken for signs of ...

  [88] Three Molecularly Targeted Drugs Tested in Kidney Cancer Clinical ...
      PDF [38,1 KB]  From [jncicancerspectrum.oxfordjournals.org]  Last viewed: 07.09.2006
Kidney cancer The kidneys are part of the urinary system. The human body has two kidneys, one on either side of the middle of the back, just under the ribs. The kidneys: • Remove waste products from the blood. • Produce hormones that regulate blood pressure, control the body's calcium levels, and trigger the production of red blood cells in bones. Around 85 per cent of kidney cancers are renal cell carcinomas. Cancer cells initially grow in the lining of one or both kidneys. Without treatment, the cancer may spread to other areas of the body. Kidney cancer is more common in people over the age of 55 years. It is more common in men than women. About 500 Victorians are diagnosed with kidney cancer every year. Symptoms In its early stages, kidney cancer may have no symptoms. The disease may be discovered by accident, when the ...

  [89] Bladder and Kidney Cancer Following Cyclophosphamide Therapy for ...
      PDF   From [jncicancerspectrum.oxfordjournals.org]  Last viewed: 07.09.2006
Kidney cancer The kidneys are part of the urinary system. The human body has two kidneys, one on either side of the middle of the back, just under the ribs. The kidneys: • Remove waste products from the blood. • Produce hormones that regulate blood pressure, control the body's calcium levels, and trigger the production of red blood cells in bones. Around 85 per cent of kidney cancers are renal cell carcinomas. Cancer cells initially grow in the lining of one or both kidneys. Without treatment, the cancer may spread to other areas of the body. Kidney cancer is more common in people over the age of 55 years. It is more common in men than women. About 500 Victorians are diagnosed with kidney cancer every year. Symptoms In its early stages, kidney cancer may have no symptoms. The disease may be discovered by accident, when the ...

  [90] Predicting survival in patients with metastatic kidney cancer by ...
      PDF [433,0 KB]  From [www.pnas.org]  Last viewed: 07.09.2006
Kidney Cancer Vaccine Shows Promise in Trial Sunday February 22, 2004 (1521 PST) ISLAMABAD, February 23 (Online): An experimental vaccine against kidney cancer has shown promising results in reducing the recurrence of the disease, German researchers said. Kidney cancer occurs mostly in adults over 40 and accounts for about three percent of all cancers. About 32,000 new cases are diagnosed each year in the United States alone. In a trial of 379 kidney cancer patients, scientists showed that the vaccine made by German biotechnology company LipoNova improved disease-free survival of patients. "For the first time ever it has been shown that additional therapy after surgery for kidney tumors is effective," said Dr Christian Doehn of the University of Lubeck Medical School in Germany. Five-year survival rates were 77 percent for patients who were given six injections ...